198 related articles for article (PubMed ID: 25459522)
1. Introduction.
Kaufmann SH
Semin Immunol; 2014 Dec; 26(6):429-30. PubMed ID: 25459522
[No Abstract] [Full Text] [Related]
2. Host-Pathogen Interaction as a Novel Target for Host-Directed Therapies in Tuberculosis.
Abreu R; Giri P; Quinn F
Front Immunol; 2020; 11():1553. PubMed ID: 32849525
[TBL] [Abstract][Full Text] [Related]
3. [Tuberculosis and nontuberculous mycobacterial infections].
Wagner D; Kern WV
Dtsch Med Wochenschr; 2011 Apr; 136(14):691-4. PubMed ID: 21448828
[No Abstract] [Full Text] [Related]
4. Latent tuberculosis infection: what we know about its genetic control?
Kondratieva T; Azhikina T; Nikonenko B; Kaprelyants A; Apt A
Tuberculosis (Edinb); 2014 Sep; 94(5):462-8. PubMed ID: 25104213
[TBL] [Abstract][Full Text] [Related]
5. Management of latent tuberculosis infection in child contacts of multidrug-resistant tuberculosis.
Adler-Shohet FC; Low J; Carson M; Girma H; Singh J
Pediatr Infect Dis J; 2014 Jun; 33(6):664-6. PubMed ID: 24445837
[TBL] [Abstract][Full Text] [Related]
6. [Expression of mRNA transcription factors RORC2 and FoxP3 in lymphocytes in patients with pulmonary tuberculosis].
Kononova TE; Urazova OI; Novitskiĭ VV; Churina EG; Zakharova PA
Tsitologiia; 2015; 57(1):56-61. PubMed ID: 25872376
[TBL] [Abstract][Full Text] [Related]
7. Mycobacterium tuberculosis strain 18b, a useful non-virulent streptomycin dependent mutant to study latent tuberculosis as well as for in vivo and in vitro testing of anti-tuberculosis drugs.
Campos-Neto A
Tuberculosis (Edinb); 2016 Jul; 99():54-55. PubMed ID: 27450005
[No Abstract] [Full Text] [Related]
8. Analyzing the interaction of pathogens with the host immune system.
Jayachandran R; Scherr N; Pieters J
Immunol Lett; 2009 Feb; 122(2):112-4. PubMed ID: 19135088
[TBL] [Abstract][Full Text] [Related]
9. Clinical Management of Drug-resistant Mycobacterium tuberculosis Strains: Pathogen-targeted Versus Host-directed Treatment Approaches.
Al-Ghafli H; Al-Hajoj S
Curr Pharm Biotechnol; 2019; 20(4):272-284. PubMed ID: 30062961
[TBL] [Abstract][Full Text] [Related]
10. Mycobacterium tuberculosis: an infection we should suspect in bone marrow transplantation.
Zanet E; Manuele R; Michieli M; Rupolo M; Berretta M; Florio F; Basaglia G; Camporese A; Tirelli U
J Chemother; 2011 Oct; 23(5):312-3. PubMed ID: 22005068
[No Abstract] [Full Text] [Related]
11. Present-day treatment of tuberculosis and latent tuberculosis infection.
Pérez-Camacho I; Rivero-Juárez A; Kindelán JM; Rivero A
Enferm Infecc Microbiol Clin; 2011 Mar; 29 Suppl 1():41-6. PubMed ID: 21420566
[TBL] [Abstract][Full Text] [Related]
12. Immunology in tuberculosis: challenges in monitoring of disease activity and identifying correlates of protection.
van Altena R; Duggirala S; Gröschel MI; van der Werf TS
Curr Pharm Des; 2011; 17(27):2853-62. PubMed ID: 21834760
[TBL] [Abstract][Full Text] [Related]
13. Recurrence of active tuberculosis following resumption of anti-TNF-α therapy in a patient with Crohn's disease.
Masiá M; Martínez M; García-Sepulcre MF; Sáez J; Gutiérrez F
Int J Tuberc Lung Dis; 2014 Feb; 18(2):249-50. PubMed ID: 24429322
[No Abstract] [Full Text] [Related]
14. Mycobacterium tuberculosis infection in transplant recipients: early diagnosis and treatment of resistant tuberculosis.
Holty JE; Sista RR
Curr Opin Organ Transplant; 2009 Dec; 14(6):613-8. PubMed ID: 19741533
[TBL] [Abstract][Full Text] [Related]
15. Beyond Killing
Divangahi M; Khan N; Kaufmann E
Front Immunol; 2018; 9():2976. PubMed ID: 30619333
[TBL] [Abstract][Full Text] [Related]
16. Multidrug-resistant tuberculosis is associated with low plasma concentrations of human neutrophil peptides 1-3.
Zhu LM; Liu CH; Chen P; Dai AG; Li CX; Xiao K; Chen Y; Cao J; Chen YR
Int J Tuberc Lung Dis; 2011 Mar; 15(3):369-74. PubMed ID: 21333105
[TBL] [Abstract][Full Text] [Related]
17. Chemokines in tuberculosis: the good, the bad and the ugly.
Monin L; Khader SA
Semin Immunol; 2014 Dec; 26(6):552-8. PubMed ID: 25444549
[TBL] [Abstract][Full Text] [Related]
18. The secret trumps, impelling the pathogenicity of tubercle bacilli.
Cardona PJ; Ivanyi J
Enferm Infecc Microbiol Clin; 2011 Mar; 29 Suppl 1():14-9. PubMed ID: 21420562
[TBL] [Abstract][Full Text] [Related]
19. Interferon-gamma release assays for childhood tuberculosis: what does the future hold?
Hesseling AC; Mandalakas AM
Int J Tuberc Lung Dis; 2011 Nov; 15(11):1423-4. PubMed ID: 22008752
[No Abstract] [Full Text] [Related]
20. Revisiting hypoxia therapies for tuberculosis.
Oehlers SH
Clin Sci (Lond); 2019 Jun; 133(12):1271-1280. PubMed ID: 31209098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
